Gene Transfer in Space

The astronauts' repair of the international space station captured media attention during the space shuttle flight in May. But inside the orbiter, a life science experiment took another small step toward creating a technology that may eventually save thousands of lives around the world. The latest trial in a study ongoing for two years, the experiment involved a gene transfer in soybeans that the researchers hope will lead to edible vaccines, among other products, in the not-too-distant future.

Written byA. J. S. Rayl
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The astronauts' repair of the international space station captured media attention during the space shuttle flight in May. But inside the orbiter, a life science experiment took another small step toward creating a technology that may eventually save thousands of lives around the world. The latest trial in a study ongoing for two years, the experiment involved a gene transfer in soybeans that the researchers hope will lead to edible vaccines, among other products, in the not-too-distant future. The Wisconsin Center for Space Automation and Robotics (WCSAR) at the University of Wisconsin, Madison, and Producers' Natural Processing (PNP), a West Lafayette, Ind., biotech company, are directing the study; it is part of the first wave of research projects in NASA's drive to commercialize space.

The payload consisted of 1,000 germinating soybean seeds. In orbit, astronauts aboard the shuttle added a solution that contained an agrobacterium as the vector to deliver ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies